|
[1]
|
Conger, R.L., Mora, J., Straza, M.W., et al. (2023) Evolution in the Presence and Evidence Category of Radiation Ther-apy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncol-ogy. Advances in Radiation Oncology, 8, Article ID: 101206. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Economopoulou, P. and Mountzios, G. (2018) The Emerging Treatment Landscape of Advanced Non-Small Cell Lung Cancer. Annals Translational Medicine, 6, Article 138. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Fox, A.H., Nishino, M., Osarogiagbon, R.U., et al. (2023) Acquiring Tissue for Advanced Lung Cancer Diagnosis and Comprehensive Biomarker Testing: A National Lung Cancer Roundtable Best-Practice Guide. CA: A Cancer Journal for Clinicians, 73, 358-375. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Villaruz, L.C., Socinski, M.A. and Weiss, J. (2023) Guidance for Clini-cians and Patients with Non-Small Cell Lung Cancer in the Time of Precision Medicine. Frontiers in Oncology, 13, Arti-cle ID: 1124167. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Lucanus, A.J. and Yip, G.W. (2018) Kinesin Superfamily: Roles in Breast Cancer, Patient Prognosis and Therapeutics. Oncogene, 37, 833-838. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Camlin, N.J., McLaughlin, E.A. and Holt, J.E. (2017) Motoring through: The Role of Kinesin Superfamily Proteins in Female Meiosis. Human Reproduction Update, 23, 409-420. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yukawa, M., Teratani, Y. and Toda, T. (2020) How Essential Kine-sin-5 Becomes Non-Essential in Fission Yeast: Force Balance and Microtubule Dynamics Matter. Cells, 9, Article 1154. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Asbaghi, Y., Thompson, L.L., Lichtensztejn, Z., et al. (2017) KIF11 Si-lencing and Inhibition Induces Chromosome Instability that May Contribute to Cancer. Genes Chromosomes Cancer, 56, 668-680. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Guo, X., Zhou, L., Wu, Y., et al. (2022) KIF11 as a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 2764940. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Liu, J., Tian, Y., Yi, L., et al. (2022) High KIF11 Expression Is Asso-ciated with Poor Outcome of NSCLC. Tumori Journal, 108, 40-46. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Gong, K., Zhou, H., Liu, H., et al. (2021) Identification and Inte-grate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis. Technology in Cancer Research & Treatment, 20, 1-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Noll, J.E, Jeffery, J, Al-Ejeh, et al. (2011) Mutant P53 Drives Multinucleation and Invasion through a Process that Is Suppressed by ANKRD11. Oncogene, 31, 2836-2848. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Fu, F., Zhang, Y., Gao, Z., et al. (2020) Development and Validation of a Five-Gene Model to Predict Postoperative Brain Metastasis in Operable Lung Adenocarcinoma. International Journal of Cancer, 147, 584-592. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Li, Z., Yu, B., Qi, F., et al. (2021) KIF11 Serves as an Independent Prog-nostic Factor and Therapeutic Target for Patients with Lung Adenocarcinoma. Frontiers in Oncology, 11, Article ID: 670218. [Google Scholar] [CrossRef] [PubMed]
|